This autophagy-independent effect highlights quercetin’s potential as a therapeutic candidate for inflammatory diseases such as IBD and Kawasaki disease vasculitis by preventing NLRP3 inflammasome activation (200). This evidence concerns the gene NLRP3 and inflammatory bowel disease.